BU-NOT-SET

CONTACT US
Optimising a prolonged release fixed dose combination product
  • Drug product
pills
Case study
Ensuring stability excellence for global consumer and OTC products
  • Analytical chemistry
  • Drug product
Woman and computer
Webinar
The impact of the COVID-19 pandemic on global pharmaceutical growth
  • Industry trends
Eyes
Insight
COVID-19: a year of unprecedented change
  • Industry trends
Eyes
Insight
Oral solids: market and technology trends
  • Drug product
Eyes
Insight
Oral modified release
  • Drug product
Granules
Fact sheet
Semi-solids an overview of current regulatory requirement
  • Drug product
Tube cream
Fact sheet
API relocation strategies for CDMO’s
  • Drug substance
Eyes
Insight
Clinical trial material
  • Drug product
  • Manufacturing
hand scooping pills
Fact sheet
Insight
  • Drug product
  • Manufacturing
How Blow-fill-seal (BFS) technology may be a superior alternative to glass vials during the early stages of a development project
White paper
  • Biologics
Product Quality in the Advanced Therapies Manufacturing
Insight
  • Biologics
Navigating ATMP fill and finish complexities
Insight
  • Biologics
The power of analytics and AI in the era of continuous RNA manufacturing
Insight
  • Biologics
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
Insight
  • Biologics
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
Insight
  • Biologics
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
Insight
  • Drug product
  • Manufacturing
Choosing the optimal container format for sterile drug products
Insight
  • Manufacturing
FDA inspection success at Recipharm’s site in Bengaluru, India